Top Banner

of 119

Aspek Psikiatrik Pada Penderita SLE

Jun 03, 2018

Download

Documents

Tami Jeba
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    1/119

    Aspek psikiatrik pada penderita SLEJurnal 1Clin Dev Immunol. 2013; 2013: 270878.

    Published online 2013 June 20. doi: 10.1155/2013/270878

    PMCID: PMC3705842

    The Correlations of Disease Activity,

    Socioeconomic Status, Quality of Life,

    and Depression/Anxiety in Chinese

    Patients with Systemic Lupus

    rythematosus

    i!u "hen#1 # 2$ei %&n#3'ui(u&n )en*#3+&n ,e#1Jin-ei iu#1$ei(un Chen#1i&oin

    ,u&n*#1h&n!un Du(u&n u#2,on* iu#3 &nd hien* 'u3 #

    uho6 ino6m&ion 6ile noes Co9!6i*h &nd iense ino6m&ion

    'o o:

    A!stract

    %he 96ev&lene o 9s!holo*i&l 96oblems is 6euen in s!semi lu9us e6!hem&osus

    "< 9&iens &nd &99e&6s o be in6e&sin*. %he u66en sud! invesi*&ed he

    6el&ionshi9 &mon* dise&se 9&6&mee6s# u&li! o lie# &nd he 9s!holo*i&l s&us in

    Chinese 9&iens -ih ". sel=6e9o6 su6ve! desi*n -&s &dminise6ed o 170 "9&iens &nd 210 he&lh! individu&ls usin* he "el=>&in* n?ie! "&le# he "el=>&in*

    De96ession "&le# &nd he "ho6 )o6m 3@ he&lh su6ve! ")=3@ dom&ins -e6e si*nii&nl! &ouned o6 &n?ie!. In summ&6!# he6e -e6e

    si*nii&n 6el&ionshi9s &mon* dise&se 9&6&mee6s# u&li! o lie# &nd &n?ie!/de96ession

    in Chinese " 9&iens. %he6eo6e# i is neess&6! o h&ve 9s!hi&6i &nd 9s!holo*i&lev&lu&ions &nd o6mul&e &n ine*6&ed &996o&h o6 m&n&*in* men&l he&lh in Chinese

    lu9us 9&iens# es9ei&ll! hose -ho h&ve hi*h dise&se &ivi!# lo- ""# &nd 9oo6 u&li!

    o lie.

    'o o:

    "# $ntroduction

    http://dx.doi.org/10.1155%2F2013%2F270878http://www.ncbi.nlm.nih.gov/pubmed/?term=Shen%20B%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Tan%20W%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Tan%20W%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Feng%20G%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Feng%20G%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Feng%20G%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=He%20Y%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=He%20Y%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Liu%20J%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Liu%20J%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Chen%20W%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Chen%20W%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Huang%20X%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Huang%20X%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Huang%20X%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Da%20Z%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Da%20Z%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Xu%20X%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Xu%20X%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Liu%20H%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Liu%20H%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Gu%20Z%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Gu%20Z%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/http://www.ncbi.nlm.nih.gov/pubmed/?term=Shen%20B%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Tan%20W%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Feng%20G%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=He%20Y%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Liu%20J%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Chen%20W%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Huang%20X%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Huang%20X%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Da%20Z%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Xu%20X%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Liu%20H%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Gu%20Z%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/http://dx.doi.org/10.1155%2F2013%2F270878
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    2/119

    "!semi lu9us e6!hem&osus "< is & h6oni inl&mm&o6! &uoimmune dise&se h&

    m&! &e muli9le o6*&n s!sems# inludin* he en6&l ne6vous s!sem CE"< F1G.

    Ps!hi&6i s!m9oms &6e 96esen in he m&(o6i! o 9&iens -ih "# &mon* -hihm&(o6 de96ession is he mos ommon 9s!hi&6i m&nies&ions F2G. De96ession

    96esened in 11BH3B o 9&iens m&! be he inii&l s!m9om beo6e he di&*nosis o

    " F3G. I -&s 6e9o6ed h& he6e -e6e 4 imes hi*he6 96ev&lene o de96ession in "om9&6ed o & m&hed# non=" 9o9ul&ion. In &ddiion# &n?ie! is uie ommon in

    " 9&iens# oen &s & 6e&ion o he illness. ini&l& &nd olle&*ues h&ve 6e9o6ed h&

    he &n?ie! diso6de6s -e6e -ie &s 96ev&len &mon* " 9&iens &s om9&6ed o heon6ols F4G.

    ven hou*h " 96esens &om9&n! -ih & -ide v&6ie! o 6e&&ble 9s!hi&6i

    s!m9oms# suh &s de96ession &nd &n?ie!# he! 6&6el! see &nd 6eeive &deu&e

    6e&men F5G. Ave6looin* &n?ie! &nd de96ession m&! h&ve seve6e onseuenes o6 he9&iens# suh &s in6e&sed inidene o &6diov&sul&6 dise&se F@G# m!o&6di&l in&6ion

    F7G# suiid&l ide&ion F8# G &nd de&h F10G# de6e&sed u&li! o lie F11#12G# dis&bili!#

    &nd he loss o em9lo!men. n!one# in u6n# &n -o6sen &n?ie! &nd de96essions!m9oms F5G.

    %he 9&ho*enesis o 9s!hi&6i s!m9oms in lu9us is sill no -ell unde6sood# bu in

    -hih *enei &nd envi6onmen&l &o6s m&! 9l&! & 9ivo&l 6ole. De96ession &nd &n?ie!

    m&! &lso be 96esen &s & 6e&ion o & se6ious 6eu66in*# 9&inul illness# -hih is&ssoi&ed -ih visible s!m9oms suh &s insomni &i*ue# &nd limied unionin* F13#

    14G. "oioeonomi s&us ""< is b6o&dl! em9lo!ed in he&lh 6ese&6h# si*n&lin* he

    im9o6&ne o soioeonomi &o6s o6 he&lh ouomes. o- "" is *ene6&ll!

    &ssoi&ed -ih hi*h 9s!hi&6i mo6bidi!# de96ession F15G# &nd mo6&li! F1@G. $hehe6de96ession &nd &n?ie! &6e &ssoi&ed -ih lu9us &ivi! 6em&ins deb&&ble.

    %he6e &6e seve6&l sudies ous on 9s!holo*i&l 96oblems in Chin& lu9us 9&iens.

    sud! 6om ,on* on* h&s ound h& &n?ie! diso6de6 -&s 96esen in 22B " 9&iens#&nd 18.2B h&d de96ession F17G. sud! 6om nhui medi&l unive6si! h&s 6e9o6ed h&

    he 96ev&lene o de96ession -&s 5.3B &nd o66el&ed -ih suiid&l ide&ion in "

    9&iens F8G. u he6e &6e e- sudies h& ous on dise&se 9&6&mee6s# u&li! o lie#

    &nd de96ession/&n?ie! in " 9&iens 6om Chin& m&inl&nd.

    %hus# he &im o his sud! -&s o e?&mine he 6el&ionshi9 &mon* dise&se 9&6&mee6s#

    u&li! o lie# &nd he 9s!holo*i&l s&us in Chinese 9&iens -ih ". Mo6eove6# -e

    -ished o &se6&in he 9ossible 6iss o &n?ie! &nd de96ession.

    'o o:

    %# Patients and &ethods

    %#"# Participants

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B2http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B3http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B4http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B6http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B7http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B8http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B9http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B10http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B11http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B12http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B12http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B13http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B14http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B15http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B16http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B17http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B8http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B2http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B3http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B4http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B6http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B7http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B8http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B9http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B10http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B11http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B12http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B13http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B14http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B15http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B16http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B17http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B8http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    3/119

    " 9&iens -e6e 6e6uied 6om ili&ed ,os9i&l o E&non* Knive6si! be-een

    J&nu&6! 2010 &nd Jul! 2011. o&l o 170 " 9&iens &nd 210 he&lh! individu&ls

    -e6e onseuivel! invied o 9&6ii9&e in & sin*le=ene6 6oss=seion&l sud!. ,e&lh!individu&ls -e6e used &s he on6ol *6ou9. ll 9&iens ulilled he 17 me6i&n

    Colle*e o >heum&olo*! C>< 6evised 6ie6i& o6 he l&ssii&ion o ". P&iens

    -e6e e?luded b&sed on he ollo-in*: 1< he! did no om9lee uesionn&i6e; 2< he!h&d omo6bidiies e.*.# se6ious ineions o6 &6di 6es9i6&o6!# *&s6oinesin&l#

    neu6olo*i&l# o6 endo6ine dise&ses< h& ould inluene " &ivi!. Con6ol sub(es

    -e6e e?luded i he! e?hibied u66en o6 hiso6! o ohe6 s!semi dise&ses o69s!hi&6i diso6de6s. %his sud! -&s &996oved b! he his Commiee o ili&ed

    ,os9i&l o E&non* Knive6si!# &nd -6ien ino6med onsen -&s ob&ined 6om &ll

    9&6ii9&ns.

    %#%# &easures of Clinical 'aria!les

    %he "!semi u9us 6!hem&osus Dise&se ivi! Inde? "DI< -&s used o

    me&su6e dise&se &ivi! F18G.

    %#(# The )evised Self*)atin+ Anxiety Scale SAS- ."0

    "" -&s used o ev&lu&e he level o &n?ie!=6el&ed s!m9oms du6in* he -ee 96io6 o

    he su6ve!. %his sel=&dminise6ed es h&s 20 uesions# -ih 15 iems 6elein*in6e&sin* &n?ie! levels &nd 5 uesions 6elein* de6e&sin* &n?ie! levels. &h

    uesion -&s so6ed on & s&le 6om 1 o 4 6&6el!# someimes# 6euenl!# &nd &l-&!s

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    4/119

    summed# &nd 6&nso6med on & s&le 6om 0 -o6s 9ossible he&lh s&e me&su6ed b! he

    uesionn&i6e< o 100 bes 9ossible he&lh s&e

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    5/119

    %&ble 2

    Co66el&ions be-een 9s!holo*i&l so6es# dise&se 9&6&mee6s# &nd u&li! o lie in "9&iens.

    (#%# Correlations !etween Psycholo+ical Scores, Disease Parameters, and

    Quality of Life in SL Patients

    P6evious sudies h&ve sho-n h& lo- soioeonomi &o6s ""< -e6e *ene6&ll!

    &ssoi&ed -ih hi*h 9s!hi&6i mo6bidi!# de96ession# &nd &n?ie! F22G. s sho- in%&ble 3# -e h&ve ound h& he6e -e6e si*nii&n o66el&ions be-een "" lo-

    edu&ion# -o6 s&us# &nd inome< &nd &n?ie!/de96ession in " 9&iens. In &ddiion#

    *ende6 &nd mens6u&l hiso6! -e6e some e?&m9les o de96ession 6is &o6s. %he6e -&s &si*nii&n 9osiive o66el&ion be-een &n?ie!/de96ession seve6i! &ssessed usin*

    ""/"D" so6e< &nd dise&se &ivi! "DI so6e

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    6/119

    %&ble 4"e9-ise 6e*6ession &n&l!ses o medi&l &nd 9s!holo*i&l v&6i&bles &nd hei66el&ionshi9 o "" in " 9&iens.

    %&ble 5

    "e9-ise 6e*6ession &n&l!ses o medi&l &nd 9s!holo*i&l v&6i&bles &nd hei66el&ionshi9 o "D" in " 9&iens.

    'o o:

    1# Discussion

    %he 96esen sud! oni6med h& Chinese " 9&iens -e6e mo6e liel! o sue6 6om

    &n?ie! &nd de96ession h&n he&lh! individu&ls. Ps!holo*i&l 96oblems si*nii&nl!

    o66el&ed -ih ""# dise&se s&us# &nd u&li! o lie. " 9&iens -ih &n?ie! &ndde96ession -e6e in lo- "" &nd h&d -o6se dise&se s&us# lo-e6 u&li! o lie. mon*

    he &ssessed 9&6&mee6s# %# P)# &nd >P s&les o ")=3@ -e6e m&(o6 on6ibuo6s o

    &n?ie! in " 9&iens# -hile dise&se &ivi! &nd %# P)# ")# &nd > dom&ins o ")=3@on6ibued o de96ession.

    "" is b6o&dl! em9lo!ed in he&lh 6ese&6h# si*n&lin* he im9o6&ne o soioeonomi

    &o6s o6 he&lh ouomes. P6evious sud! h&s ound h& 9oo6e6 o9in* s!les# on*oin*

    lie evens# s6ess e?9osu6e# &nd -e&e6 soi&l su99o6 -e6e some e?&m9les o de96ession6is &o6s h& -e6e mo6e 96ev&len in lo-e6 "" *6ou9s F23G. >e*&6din* he di6eion

    o he &ssoi&ion o6 "" &nd de96ession# 6esuls mo6e onsisenl! su99o6ed he ide&

    h& &us&ion lo- "" in6e&ses 6is o de96ession< ou-ei*hed seleion de96essionhinde6s soi&l mobili!

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    7/119

    )em&le *ende6 &nd !oun*e6 &*e h&ve -ell=no-n &ssoi&ions -ih de96ession &nd

    onound he "" &n?ie!/de96ession 6el&ionshi9 in " F28G. In he 96esen sud!#

    *ende6 -&s inde9endenl! &ssoi&ed -ih de96ession in ". Ine6esin*l!# -e h&veound h& he6e -e6e si*nii&n o66el&ion be-een &bno6m&l mens6u&l hiso6! &nd

    de96ession. $hehe6 &n?ie!/de96ession is &ssoi&ed -ih lu9us &ivi! 6em&ins

    deb&&ble. $&le6 " &nd olle&*ues 6e9o6ed h& he &n?ie! seve6i! did o66el&e9osiivel! -ih " &ivi! F2G. Ee6! e &l. 6e9o6ed & si*nii&n 9osiive o66el&ion

    be-een de96ession &nd dise&se &ivi! F30G. In on6&s# ohe6 sudies 6e9o6ed h& he6e

    -&s no 6el&ionshi9 be-een lu9us &ivi! &nd 96esene o & m&(o6 de96essive e9isodeF31G. In he 96esen sud!# ou6 *6ou9 ound si*nii&n 9osiive o66el&ion be-een

    &n?ie!/de96ession &nd dise&se &ivi!. ,e&lh=6el&ed u&li! o lie in lu9us -&s ound

    o be si*nii&nl! -o6se in om9&6ison -ih on6ol *6ou9. >een sud! 6e9o6ed h&

    " 9&iens -ho h&d si*nii&nl! 9oo6e6 he&lh=6el&ed u&li! o lie -e6e si*nii&nl!mo6e de96essed &nd &n?ious h&n hei6 he&lh! oune69&6s F11G. $e h&ve &lso ound he

    PC" &nd MC" &nd &ll 8 dom&ins o ")=3@ e?e9 P -e6e si*nii&nl! -o6se h&n

    on6ol sub(es. %he 6esuls -e6e simil&6 -ih he sud! 6om ,on* on*. $e h&ve &lso

    ound h& he "DI so6es -e6e & s6on* 96edio6 o de96ession in 9&iens -ih ".

    Eo&bl!# he 6esuls o he 96esen sud! demons6&ed h& &n?ie! in Chinese "

    9&iens die6s 6om " 9&iens in ohe6 oun6ies. %his ould be e?9l&ined b! some

    ulu6&l e&u6es -hih m&! inluene men&l dise&se di&*nosis &nd m&n&*emen inChin&. $e h&ve ound h& he 96ev&lene o de96ession -&s hi*he6 h&n ,on* on*# &nd

    i mi*h be due o ulu6&l die6enes &nd "" suh &s inome &nd medi&l insu6&nes

    9oli!.

    In o6de6 o ideni! -hih v&6i&bles -e6e mos si*nii&nl! o66el&ed -ih &n?ie! &ndde96ession# se9-ise 6e*6ession &n&l!sis -&s used. $e h&ve ound h& %# P)# &nd >P

    s&les o ")=3@ -e6e he mos 9o-e6ul 96edio6s o &n?ie! o " 9&iens.Me&n-hile# "DI# %# P)# ")# &nd > dom&ins o ")=3@ -e6e si*nii&nl! &ounedo6 &n?ie!. I ould be e?9l&ined h& im9&i6ed u&li! o lie &nd union&l dis&bili!

    -e6e inde9enden 6is &o6s o6 9s!holo*i&l diso6de6s.

    9ossible limi&ion o he 96esen sud! -&s h& &ll 9&iens involved in he su6ve! -e6e

    6om onl! one ene6 &nd is &ilu6e o die6eni&e be-een men &nd -omen; he *ende6die6enes in " 9&iens 6eui6e u6he6 &n&l!sis in & uu6e sud!. nohe6 limi&ion

    o he sud! -&s h& -e did no dee he im9& o 96oinl&mm&o6! !oines on

    de96ession. >een sud! 6e9o6ed h& hi*he6 se6um %E)=level -&s inde9endenl!&ssoi&ed -ih 9oo6e6 he&lh=6el&ed u&li! o lie &nd mo6e seve6e de96essive

    s!m9oms in " 9&iens in "in*&9o6e F11G.

    In summ&6!# ou6 sud! indi&ed h& 9s!holo*i&l 96oblems -e6e 6euen in Chinese

    " 9&iens. "eve6e dise&se s&us &nd 6edued u&li! o lie si*nii&nl! o66el&ed-ih &n?ie! &nd de96ession. Dise&se &ivi! -&s hi*he6 in &n?ious &nd de96essed

    sub*6ou9s. Qu&li! o lie -&s de6e&sed in de96essed sub*6ou9s. Im9&i6ed men&l he&lh

    &nd 9&in -e6e he mos 9o-e6ul 96edio6s o &n?ie! &nd de96ession. o- "" -&sinde9endenl! &ssoi&ed -ih 9oo6 men&l he&lh. %hese indin*s oni6med he

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B28http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B30http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B31http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B29http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B11http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B11http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B28http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B30http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B31http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B29http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B11http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705842/#B11
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    8/119

    im9o6&ne o 9s!hosoi&l ine6venions in ombin&ion -ih medi&l he6&9! o6 "

    9&iens.

    'o o:

    Authors5 Contri!ution

    i!u "hen &nd $ei %&n on6ibue eu&ll! o his -o6.

    'o o:

    Ac6nowled+ments

    %he &uho6s -&n o h&n i6en i# in*h&n* hu# 'en&i 'uo# Jie Qi&n# ,&i?i& C&o#&nd +unei i& o6 hei6 &ssis&ne -ih his 9&9e6. %his -o6 -&s su99o6ed b! he

    E&ion&l E&u6&l "iene )ound&ion o Chin& '6&n no. 81172841# "hu&6d D$. Eeu6o9s!holo*i&l

    im9&i6men in s!semi lu9us e6!hem&osus: & om9&6ison -ih muli9le sle6osis.Neuropsychology Review. 2008;182

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    9/119

    @. '6eo CM# i %# "&&6 # e &l. ssoi&ion be-een de96ession &nd v&sul&6 dise&se

    in s!semi lu9us e6!hem&osus.Journal of Rheumatology. 2012;32

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    10/119

    22. ems6& M# Eeudo6 C# DT6! C# uns # $&66en M# enne E>. s!sem&i

    6evie- o de96essed mood &nd &n?ie! b! "" in !ouh &*ed 10H15 !e&6s. Canadian

    Journal of Pu&lic 'ealth. 2008;2J# lo!d D. %he s6ess 96oess &nd he soi&l dis6ibuion o de96ession.

    Journal of 'ealth and #ocial (ehavior. 1;404

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    11/119

    8!9ective

    %he 9u69ose o his sud! -&s o esim&e he 96ev&lene &nd e?&mine he 96edio6s ode96ession in 9&iens -ih s!semi lu9us e6!hem&osus "&in* "&le ,M=D17eenl!# & sud! o 9&iens -ihs!semi sle6osis sho-ed h& 1=!e&6 &nd lieime 96ev&lene 6&es o MDD -e6e 11B

    &nd 23B 6es9eivel!.2%hose 6&es &6e &996o?im&el! -ie h& o he *ene6&l

    9o9ul&ion.2"imil&6l!# 6een evidene su**ess h& he 96ev&lene o de96ession in&ne6 9&iens is &s hi*h &s 30B &nd de96essive seve6i! is &ssoi&ed -ih seve6i! o

    9h!si&l 9&in.3

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b1-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b1-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b2-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b2-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b2-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b3-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b1-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b2-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b2-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b3-ndt-9-799
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    12/119

    "!semi lu9us e6!hem&osus "< is & h6oni &uoimmune dise&se -hih usu&ll!

    &es muli9le o6*&n s!sems inludin* he en6&l ne6vous s!sem.4#5%he6eo6e# i &n

    &use seve6&l neu6o9s!hi&6i s!nd6omes# inludin* de96ession.@#7>een evidenesu**ess h& he 96ev&lene o de96ession in " 9&iens is be-een 11.5B &nd 47B.8H

    13In &ddiion# & 6een sud! su**ess h& seve6i! o de96ession in6e&ses -ih mo6e

    seve6e dise&se &ivi! o ".14%he e?ended lie s9&n o " 9&iens 6om u66en&dv&nes in mediine le&ds hese 9&iens o enoune6 & 6el&9sin* &nd 6emiin* ou6se o

    he dise&se &nd &dve6se evens 6om seve6&l 6e&mens h& m&! dee6io6&e hei6 u&li!

    o lie &nd inim&e 6el&ionshi9s# &nd m&! 96ei9i&e de96ession.15#1@In &ddiion# hebu6den o " omo6bid -ih de96ession m&! in6e&se he 6is o suiide.17

    lhou*h &-&6eness o 9s!hi&6i om9li&ions h&s in6e&sed &mon* 9h!sii&ns &nd

    ohe6 he&lh 96oession&ls# lile 6ese&6h ouses on de96essive &s9es o ".

    %he6eo6e# he &im o he u66en sud! -&s o dee6mine he 96ev&lene o de96essivediso6de6s in " 9&iens &nd o ideni! 6is &o6s.

    5o to:

    &aterial and methods

    Patients

    %he sud! used he lini&l d&& 6om he 6oss=seion&l " sud!. P&iens -e6e

    6e6uied 6om he >heum&olo*! Clini o Knive6si! ,os9i&l# Chi&n* M&i Knive6si!#%h&il&nd.18ll " 9&iens# &*ed 18H@0 !e&6s# ulillin* he inlusion 6ie6i& o6 hei6

    di&*nosis b&sed on he 6evised me6i&n Colle*e o >heum&olo*! C>&in* "&le ,M=D17&in* "&le ,M=

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    14/119

    inluded in muli9le line&6 6e*6ession &n&l!sis &s inde9enden v&6i&bles. Mo6eove6# ohe6

    &o6s -hih h&d si*nii&n die6enes P 0.1< -e6e &lso inluded in he &n&l!ses

    &*e# hiso6! o CE" involvemen &nd & numbe6 o lieime medi&ions su&6e W 0.7# Du6bin=$&son W 1.7@< see %&ble 3

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    15/119

    96ev&len h&n h& o he *ene6&l 9o9ul&ion in -hih he 9oin &nd lieime 96ev&lene is

    @.1B &nd 10.3B# 6es9eivel!.1%he hi*h mo6bidi! o de96ession in " -&66&ns

    oninuin* 6ese&6h &nd e?9&nsion o eo6s in he lini&l sein* o o9imiSe 6e&mens.

    Com9&6ed -ih he *ene6&l 9o9ul&ion# &n?ie! is &nohe6 ommon 9s!hi&6i

    m&nies&ion in " 9o9ul&ions. 6een sud! ound h& he 30 d&! &nd lieime96ev&lene o6 &n?ie! in " 9&iens# inludin* &*o6&9hobi& -ihou 9&ni diso6de6#

    *ene6&liSed &n?ie! diso6de6 &nd ohe6 &n?ie! diso6de6# -e6e [email protected] &nd 52.1B#6es9eivel!.28"imil&6l!# &nohe6 *6ou9 ound h& he 96ev&lene o &n?ie!# &s

    me&su6ed b! he ,M=# -&s &s hi*h &s @5.7B.30e&use o he hi*h 96ev&lene o

    &n?ie!# individu&l " 9&iens should unde6*o 9s!hi&6i &ssessmen o6 &n?ie!.

    In *ene6&l# he 6el&ionshi9 be-een de96ession &nd &n?ie! in 9&iens &6oss die6en

    &*es -ih h6oni som&i dise&se h&s been 6e9o6ed. >eenl!# he evidene su**ess h&

    he &n?ie! 6&i is & si*nii&n dee6min&n o de96essive s!m9oms in 9&iens -ih

    b6e&s &ne6.31%he 6een sud! o 9&iens -ih 9&in s!m9oms &lso su**ess h&

    &n?ie! &nd de96ession m&! o66el&e 9osiivel!.32In &ddiion# he si*nii&n6el&ionshi9 be-een hem h&s been 6e9o6ed in he &dv&ned &ne6 9&iens -ih medi&n

    &*e o 5 !e&6s 6&n*e 20H1 !e&6s&in* "&le MD>"e&sons o6 hese die6in* 6esuls &6e unle&6. ,o-eve6# one 9ossible e?9l&n&ion o6 he

    die6en indin*s is he 9oeni&ll! onoundin* inluene o 96ednisolone# & medi&ion-hih &n indue de96ession.37Me&n doses o 96ednisolone in & 96evious sud! -e6e

    18.28 m*/d&! o6 he m&(o6 de96essive diso6de6 MDD< *6ou9 &nd 15.0 m*/d&! o6 he

    non=MDD *6ou9#3@-hile me&n doses o his medi&ion in ou6 sud! -e6e less h&n h&o & 96evious sud!.3@)u6he6 6ese&6h -ih & l&6*e6 s&m9le siSe &nd -ell=on6olled

    sud! mehodolo*! m&! l&6i! hese 9henomen&.

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b1-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b1-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b28-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b28-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b30-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b30-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b31-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b31-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b31-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b32-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b32-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b33-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b34-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b34-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b35-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b36-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b37-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b37-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b36-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b36-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b1-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b28-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b30-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b31-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b32-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b33-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b34-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b35-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b36-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b37-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b36-ndt-9-799http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678948/#b36-ndt-9-799
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    16/119

    CE" involvemens in " m&! be one o he m&(o6 &uses o mo6bidi! &nd mo6&li!. I

    is &lso &ssoi&ed -ih 9s!hi&6i m&nies&ions# 9&6iul&6l! in 9s!hosis 23B

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    17/119

    2. "e/ett >, >a?y+o (, uso! &, *aro! &, Thobs *D, o! behal o the'a!aia! %cleroera >esearch 5. Preale!ce o curre!t, 12@o!th a!lietie aAor epressie isorer ao!- patie!ts /ith systeic sclerosis.>heuatolo-y. 2013;#24:))9)7#. , >obi!so! &, rstro!- , *ar!es H, Cilbour! C&, >ichars*. ati-ue i! systeic lupus erytheatosus: co!tributio!s o iseaseactiity, pai!, epressio!, a! perceie social support. " >heuatol.200#;329:1)99170#.

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    18/119

    17. Iie , 'he! P, Pa! , et al. Preale!ce a! correlates o suicialieatio! i! % i!patie!ts: 'hi!ese e6perie!ce. >heuatol (!t.2012;329:27072714. heuatol. 2004;3111:21#)21)2.

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    19/119

    34. &a+ , Ta!- '%, 'ha! &, 'hea+ , o >'. Daa-e accrual, cuulatie-lucocorticoi ose a! epressio! preict a!6iety i! patie!ts /ith systeiclupus erytheatosus. 'li! >heuatol. 2011;30):79#803. , "oh!so! '>, et al. The i!cie!ce a! preale!ceo !europsychiatric sy!roes i! peiatric o!set systeic lupuserytheatosus. " >heuatol. 2002;297:1#3)1#42. heu.1981;2411:1389139#.

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    20/119

    Deb6iein* ine6vie-s o sub(es -ih " *uided he l&n*u&*e modii&ions o he

    ool. %he 96oess o &d&9&ion 96oeeded &o6din* o he *uideline &nd 96e=esin*

    6esuls o u9usQo=Chin&. 220 " 9&iens om9leed u9usQo=Chin& &nd & *ene6i96ee6ene=b&sed me&su6emen o he&lh u6oQo s&le Q=5D< &nd es=6ees %>%< 6eli&bili!#

    onve6*en &nd dis6imin&n v&lidi! -e6e e?&mined. )&o6 &n&l!sis &nd >&sh &n&l!sis-e6e 9e6o6med.

    )esults

    %he me&n "D< &*e o he 208 sub(es -ih " -&s 33.3 O.1< !e&6s. IC> &nd %>%o he ei*h dom&ins 6&n*ed 6om 0.811 o 0.@5 &nd 0.83@ o 0.74# 6es9eivel!. %he

    u9usQo=Chin& dom&ins demons6&ed subs&ni&l evidene o ons6u v&lidi! -hen

    om9&6ed -ih euiv&len dom&ins on he Q=5D 9h!si&l he&lh &nd usu&l &iviies 6 WX0.@3# 9&in &nd 9&in/disomo6 6 W X0.778# emoion&l he&lh &nd &n?ie!/de96ession 6 W

    X0.7@1# 9l&nnin* &nd usu&l &iviies 6 W X0.5@0Qo< is desi6&ble. ,>Qo &ssessmen h& ev&lu&es 9&iensT he&lh s&us &nd

    9e6son&l sense o -ell bein* m&! mo6e &u6&el! 6ele he bu6den o " dise&se

    &mon* 9&iens. %he6eo6e &u6&e ,>Qo &ssessmen o 9&iens -ih " is desi6&ble&nd d6&-s in6e&sin*l! &enion.

    ITs no-n h& ,>Qo &mon* 9&iens -ih " is -o6se h&n he *ene6&l 9o9ul&ion#

    9&6iul&6l! hose &ll viim & &n e&6lie6 &*eF4G. P6io6 sudies o ,>Qo in " h&veem9lo!ed *ene6i ools# suh &s he "ho6 )o6m=3@ ")=3@< F5G# u6oQo s&le Q=5DQo ools h&ve been v&lid&ed in M&inl&nd Chinese. o6din* o oii&l

    -ebsie o u9usQoh9://lu9usol.om/Qo o " 9&iens in M&inl&nd Chin& m&! benei 6om s9eiidie6enes 6om %&i-&n. Au6 ob(eive -&s o 6oss=ulu6&ll! &d&9 he u9usQo o

    M&inl&nd Chinese# &nd ev&lu&e is me&su6emen 96o9e6ies.

    5o to:

    Patients and &ethods

    Demo+raphic Data

    %his sud! -&s &996oved b! he insiuion&l 6evie- bo&6d o "h&n*h&i Ji&oon*

    Knive6si!# &nd &ll sub(es onsened o 9&6ii9&ion. $e inluded onseuive "

    9&iens n W 220< -ho h&d been ollo-ed u9 & >en Ji ,os9i&l# "hool o Mediine#"h&n*h&i Ji&o %on* Knive6si! 6om M&6h o Eovembe6 o 2012. %he inlusion 6ie6i&

    -e6e &s ollo-s: &*e be-een 18 &nd 75 !e&6s# &nd di&*nosis o " &o6din* o he

    17 modiied C> 6ie6i& F11G. Demo*6&9hi ino6m&ion inluded se?# &*e# &*e &dise&se di&*nosis# edu&ion &nd m&6i&l s&us.

    LupusQoL

    u9usQo is & lu9us=s9eii ,>QA uesionn&i6e onsisin* o 34 iems *6ou9ed in

    ei*h dom&ins: 9h!si&l he&lh P,

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    22/119

    6om he sel=l&ssiie6# -he6e 1 6e96esens ull he&lh &nd 0 6e96esens de&d. "o6es o6

    he ive dom&ins o he Q=5D -e6e *ene6&ed.

    Disease Characteristics

    Dise&se &ivi! -&s dee6mined usin* he " Dise&se ivi! Inde? "DI< ool F14G.

    "ICC/C>=DI 6&s i66eve6sible o6*&n d!sunion &6oss 12 s!sems. %he d!sunionmus be 96esen o6 @ onseuive monhs in o6de6 o 6e*ise6 &s d&m&*e. %he so6e 6&n*es

    6om 0 o 4@# -ih hi*he6 so6es si*ni!in* mo6e d&m&*e.

    Statistical Analyses

    $e used "P"" so-&6e# ve6sion 10.0 o &n&l!Se d&&. Des6i9ive s&isis -e6e6e9o6ed. %he oninuous v&6i&bles -e6e esed o6 no6m&li!; & non=9&6&me6i es

    M&nn=$hine!< -&s used o6 om9&6in* oninuous d&&.

    Content 'alidity

    s u9usQo -&s modiied 6om & 96e=e?isin* %&i-&n ve6sion# i -&s &ssumed h& i

    h&d & *ood onen v&lidi!. $e &sed he 96e=es s&m9le o 9&iens -hehe6 he iems-e6e unde6s&nd&ble# &nd m&de mino6 h&n*es o he e?96ession &o6din* he eedb&.

    $nternal Consistency )elia!ility

    C6onb&hTs Y -&s used o es o6 ine6n&l onsisen!# &nd -&s onside6ed s&is&o6!-hen Z0.7F15G.

    Test*retest )elia!ility

    %es=6ees 6eli&bili! -&s dee6mined usin* &n in6&l&ss oeiien o &ssess he s&bili!o he me&su6e# om9&6in* u9usQo=Chin& dom&ins so6es & b&seline &nd 2 -ees

    l&e6 in 9&iens n W 20< -hose sel=&ssessed u&li! o lie -&s 6&ed &s no h&n*e on &

    15=9oin he&lh s&us h&n*e s&le X7 o [7

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    23/119

    "ICC=DI so6e uo o 1. nd hen dis6imin&n ons6u v&lidi! usin* M&nn=

    $hine! non=9&6&me6i ess -&s &essed.

    Conver+ent 'alidity

    $e me&su6ed he e?en o o66el&ion be-een obse6ved 6el&ionshi9s o he one9s&nd he h!9ohesiSed one9s o &ssess is onve6*en v&lidi!. s6on* o66el&ion -&s

    deined &s Z0.70# mode6&e o subs&ni&l &s 0.30H0.70 &nd -e& &s 0.30.

    :actor Analysis

    $e ondued &n e?9lo6&o6! &o6 &n&l!sis )< F96ini9&l om9onen &n&l!sis P)&sh &n&l!ses# 6esuls in i &n&l!ses o iems -ihin e&h dom&in -e6e &e9&ble

    me&n su&6e ouis -e6e &ll \0.@ &nd none -&s \2 %&ble 5QoF22GHF24G. %o ou6 no-led*e# he6e h&s been no "=

    s9eii ,>Qo ools h& h&ve been v&lid&ed o6 use &mon* M&inl&nd Chinese 9&iens.Me&n-hile# *ene6i ools -e6e no desi*ned o6 " 9o9ul&ion# so he! m&! on&in

    i66elev&n iems &nd/o6 l& iems deemed im9o6&n o hese 9&iens# &nd m&! be less

    sensiive h&n & dise&se=s9eii me&su6e F25G# F2@G. o6din*l!# i is desi6&ble o ind &n"=s9eii ,>Qo ool v&lid&ed o6 use in Chinese 9&iens.

    $e modiied he u9usQo=%&i-&n ins6umen o ev&lu&e in M&inl&nd Chinese 9&iens#

    &nd &ssessed is me&su6emen 96o9e6ies. e&use he6e &6e no 9ublished d&& &bou

    v&lidi! &nd 6eli&bili! o u9usQo=%&i-&n 9ublished# -e om9&6ed ou6 6esuls -ih heo6i*in&l ve6sion u9usQo=K< &nd u9usQo=K" in ou6 sud! F8G# FG.

    Au6 6esuls 96ovide evidene h& he u9usQo=Chin& is & v&lid ool o &ssess he u&li!o lie o " 9&iens# &nd i is he i6s 96o9osed "=s9eii ,>Qo ool h& m&! be

    &99lied o &ll Chinese 9&iens.

    %he IC> esim&es o he u9usQo=Chin& -e6e simil&6 o hose o he u9usQo=K.

    %he onve6*en &nd dis6imin&n v&lidi! o he ool -e6e *ood. In ou6 d& he dom&in

    o inim&e 6el&ionshi9 -hih 6eles se?u&l he&lh &n &lso die6eni&e be-eendise&se seve6i! &s -ell &s ohe6 dom&ins. $e su**es h& his 6esul m&! be 6el&ed o he

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/table/pone-0063795-t005/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/table/pone-0063795-t005/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-Cervera1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-Li1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-Daleboudt1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-NavarreteNavarrete1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-Thumboo1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-Murawski1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-McElhone1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-Jolly1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/table/pone-0063795-t005/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/table/pone-0063795-t005/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/table/pone-0063795-t005/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-Cervera1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-Li1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-Daleboudt1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-NavarreteNavarrete1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-Thumboo1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-Murawski1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-McElhone1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662722/#pone.0063795-Jolly1
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    27/119

    Chinese &iude o-&6d se?u&l ine6ou6se. %6&diion&l one9s in Chinese ulu6e

    onside6 ine6ou6se o be de6imen&l o he&lh. $hen Chinese 9&iens beome ill# he!

    end o 6e96ess se?u&l desi6es &nd hoose o om96omise hei6 se? lie# es9ei&ll! in &seso seve6e dise&se.

    Au6 e?9lo6&o6! &o6 &n&l!sis -ihou ons6&inin* &o6 numbe6s sho-ed & @=&o6lo&din* model; ho-eve6# he 6esuls o IC> &nd oni6m&o6! &o6 &n&l!sis h&n*ed

    lile. o6din* o he des6i9ion o iems# -e believe he o6i*in&l 8=&o6 model isbee6.

    %o ensu6e he v&lidi! o es=6ees 6eli&bili!# -e hoose -o -ees &s he ime ine6v&l

    be-een -o ess# -hih is one -ee lon*e6 h&n in he o6i*in&l ve6sion o u9usQo.%his du6&ion -o -ees< -&s seleed be&use i -&s suiienl! lon* enou*h o6

    9&iens o o6*e hei6 o6i*in&l 6es9onses &nd sho6 enou*h o6 he dise&se s&e o 6em&in

    unh&n*ed F27G. %he >&sh model &n&l!sis &lso su**esed h& he u9usQo -&s -ell=

    unde6sood o6 ou6 9&ien oho6.

    ITs im9o6&n o noe h& be&use he *ene6&ion 9h&se o iems -&s ondued in he

    K# -hih inluded 96edomin&nl! C&u&si&n 9&iens# he h&6&e6isis o Chinese

    9&iens -ih " m&! no be 6eleed om9leel!. In &ddiion# he die6ene be-een

    -o oun6! in soioeonomi s&us &nd medi&l &6e se6vies# -hih m&! im9& he&lhs&us# m&! oune6 he &e v&lidi! o he ool -hen used &mon* Chinese " 9&iens

    F28G.

    Conclusions

    In summ&6!# ou6 6ese&6h 96ovides evidene o v&lidi! &nd 6eli&bili! o he modiied

    u9usQo ve6sion u9usQo=Chin&< &mon* M&inl&nd Chinese 9&iens -ih ".ddiion&l l&6*e6 sudies &6e sill 6eui6ed o u6he6 &ssess he 9s!home6i 96o9e6ies&nd o9im&l &o6 s6uu6e# &nd 6esolve is 6ole in lini&l 6i&ls &nd 6ouine 96&ie. $e

    ho9e h& his sud! -ill 96om9 u6he6 &enion o me&su6emen o ,>Qo in "

    9&iens# -hih -ill ulim&el! le&d o mo6e eiien lini&l m&n&*emen o "9o9ul&ion.

    5o to:

    Supportin+ $nformation

    Ta!le S"

    xploratory :actor Analysis with < factor constraints#?6&ion Mehod: P6ini9&l

    Com9onen n&l!sis. >o&ion Mehod: &6im&? -ih &ise6 Eo6m&liS&ion.

    DACheu #1: 4)#474.

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    29/119

    ). %ullia! P, 5hushchya! H 200) Preere!ce@*ase L@#D i!e6 scoresor chro!ic co!itio!s i! the E!ite %tates. &e Decis &a+i!- 2): 410420., Teh %, et al. 2010 upus@speciBc health outcoe easure or E% patie!ts: the upusLo@E% ersio!.!! >heu Dis )9: 2933. heu 39: 3)33)9. , >eic+i D 200# >eliability a! aliity i!clui!-respo!sie!ess. (!: ayers P, eitor. ssessi!- Juality o lie i! cli!ical trials.M6or: M6or E!iersity Press. 2#39.1). or! " 19)# >atio!ale a! Test or the Nuber o actors i! actor!alysis. Psychoetri+a 30: 17918#. 2009 >eporti!- practices i!co!Bratory actor a!alysis: a! oerie/ a! soe recoe!atio!s.Psychol &ethos 14: )23. asch a!alysiso the Juality o lie a! isio! u!ctio! Juestio!!aire. Mpto His %ci 8):83)844. heuatolo-y M6or #1: 721729.

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    30/119

    22. Dalebout 5&, *er-er %P, *roabe!t , Captei! 2011 ealth@relateJuality o lie i! patie!ts /ith systeic lupus erytheatosus a! prolieratielupus !ephritis. Psychol ealth &e 1): 393404. heuatol 39: 73#742. aire? &(, %abio "&, &arti!e?@-ea (,%a!tos@>ui? , et al. 2010 Luality@o@lie preictor actors i! patie!ts /ith% a! their oiBcatio! ater co-!itie behaioural therapy. upus 19:1)321)39. heuatol 2): 1#121#17. es 7: 1122. heu #9: 10471048; author reply 10481049.

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    31/119

    "!semi lu9us e6!hem&osus "< is & muli=s!sem inl&mm&o6! diso6de6

    h&6&e6iSed b! he 96esene o seve6&l &uo&nibodies# inludin* &ni=double=s6&nded

    DE. Eeu6o9s!hi&6i EP2 &nibod!# 6es9eivel!. In &(MC Medicine6ese&6h &6ile#ivi! e &l. demons6&ed novel -o6 sho-ed h& he 1@/@ Id &nibod! im9&i6ed visu&l

    memo6! &nd s9&i&l memo6! b! &usin* hi99o&m9&l in(u6! in mie. 'iven die6enes in

    he 6oss=6e&ivi! o e&h &uo&nibod! -ih he ne6vous s!sem# he lini&l e&u6es

    mi*h be die6en &nd dive6se in EP. Idenii&ion o &uo&nibod! &6*es ould le&do he develo9men o novel he6&9ies. Invesi*&o6s &nd linii&ns should onside6 no

    onl! he inhibiion o &uo&nibod! s!nhesis bu &lso he 96oeion o neu6on&l ells in

    he 6e&men s6&e*! o6 EP.

    "ee 6el&ed >ese&6h &6ile: h9://---.biomeden6&l.om/1741=7015/11/0

    >eywords7 "!semi lu9us e6!hem&osus# uo&nibod!# C6oss=6e&ivi!#

    Eeu6o9s!hi&6i s!m9oms

    'o o:

    $ntroduction

    "!semi lu9us e6!hem&osus "< is & muli=s!sem inl&mm&o6! diso6de6

    h&6&e6iSed b! he 96esene o &uo&nibodies di6eed &*&ins double=s6&nded dseen novel sudies h&ve ideniied some &s9es o he 9&ho9h!siolo*! o EP.

    "ome &ni=dsDE &nibodies 6oss=6e& -ih heN=meh!l=D=&s9&6&e EMD2< in " F3G. EMD 6ee9o6s &6e li*&nd=*&ed ion h&nnels h&9l&! 6ui&l 6oles in s!n&9i 6&nsmission &nd CE" 9l&sii!. EMD 6ee9o6

    d!sunion h&s been im9li&ed in muli9le b6&in diso6de6s# inludin* s6oe# h6oni

    neu6ode*ene6&ion# e9ile9s!# &nd shiSo9h6eni&. ni=E>2 &nibodies b6e&hin* hebloodHb6&in b&66ie6 < &n &use neu6on&l d&m&*e vi& &n &9o9oi 9&h-&! F4#5G.

    %he 1@/@ idio!9e Id< &nibod!# -hih -&s he ous o & 6een sud! b! ivi! e &l. F@G#

    is onside6ed o be &n &ni=dsDE Id &nibod! in ". ImmuniS&ion o n&ive mie -ih

    he hum&n 1@/@ Id monolon&l &nibod! indued &n "=lie dise&se h&6&e6iSed b!se6olo*i&l# lini&l# &nd 9&holo*i&l e&u6es. %his &nibod! 6oss=6e&s -ih

    !osele&l 96oeins# *l!o96oeins# &nd b6&in *l!oli9ids# &s -ell &s -ih 9&ho*ens suh

    &sMyco&acterium tu&erculosisF7G. De9osiion o 1@/@ Id &nibodies h&s been ound inhum&n issues# suh &s he sin# idne!# &nd b6&in F8G# &nd levels &6e hi*h in 9&iens -ih

    &ive " o6 EP FG. %hese indin*s indi&e h& he 1@/@ Id &nibod! is 9oeni&ll!

    one o he &o6s h& &use EP. ,o-eve6# he -&! in -hih hese neu6o9s!hi&6is!m9oms &6e indued b! he 1@/@ Id &nibod! 6e&hin* he CE" &nd he unde6l!in*

    meh&nisms o his induion &6e unno-n. In hei6 sud!# ivi! e &l. sho-ed o6 he

    i6s ime he ee o he 1@/@ Id &nibod! on he CE" b! in(ein* n&ive mie

    in6&e6eb6oven6iul&6l! -ih he 1@/@ Id &nibod! F@G. In his ommen&6!# -e disusshei6 6esuls &nd he 9&ho9h!siolo*! &nd 6e&men s6&e*! o6 EP.

    ?eurolo+ical effects of the "4/4 $d anti!ody

    %o unde6s&nd i he 1@/@ Id I*' &nibod! is &ble o indue neu6olo*i&l ees# ivi! e&l. om9&6ed he o*niive &nd beh&vio6&l 9e6o6m&ne o C3, em&le mie h& h&d

    been in(eed -ih he hum&n 1@/@ Id I*' &nibod! 1@/@ Id mie subse< &nd hosein(eed -ih & omme6i&l hum&n I*' on6ol mie subse< F@G. isu&l=6eo*niionmemo6! -&s &ssessed b! usin* he novel=ob(e 6eo*niion es. %he &uho6s ound h&

    he6e -&s & si*nii&n 96ee6ene o6 &enion o he ne- ob(e om9&6ed -ih he old

    ob(e b! he on6ol mie# bu no die6ene in 96ee6ene -&s ound be-een he ne-&nd he old ob(es b! he 1@/@ Id mie. %his 6esul indi&es im9&i6men o visu&l=

    6eo*niion memo6! in he 1@/@ Id mie. In he +=m&Se es# -hih &ssesses s9&i&l

    memo6!# he 1@/@ Id mie -e6e &lso ound o h&ve im9&i6men o s9&i&l memo6!.

    In &ddiion# he b6&in 9&holo*! o hese mie -&s e?&mined o es&blish he 9oeni&lmeh&nism b! -hih he 1@/@ Id I*' &nibod! is &ble o e?e6 is neu6olo*i&l ees. In

    he b6&in issue# in6e&sed mi6o*li&l &iv&ion -&s seen in he hi99o&m9us &nd&m!*d&l bu no in he neu6oo6e? o6 9i6io6m o6e?. In &ddiion# he numbe6 o&s6o!es in he hi99o&m9us -&s ound o be in6e&sed. %&en o*ehe6# hese 6esuls

    sho- h& in mie# he 1@/@ Id &nibod! &uses im9&i6men o boh visu&l &nd s9&i&l

    memo6! h6ou*h hi99o&m9&l in(u6!# &nd mi*h seleivel! 6oss=6e& -ih some

    &ni*ens in he hi99o&m9us.

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B3http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B4http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B6http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B7http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B8http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B9http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B6http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B6http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B3http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B4http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B6http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B7http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B8http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B9http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B6http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B6
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    33/119

    The "4/4 $d anti!ody is a novel anti!ody contri!utin+ to the

    pathophysiolo+y of ?PL

    ivi! e &l. &lso sho-ed h in &ddiion o he &ni=6ibosom&l P &nd &ni=E>2&nibodies# &nohe6 &uo&nibod!# &ni=1@/@ Id &nibod!# &n 6oss=6e& -ih hum&n b6&in

    issue &nd &use EP s!m9oms in " F@G. 6&in issue=6e&ive &nibodies in EP&6e hou*h o be s!nhesiSed in he CE" o6 9e6i9he6&l o6*&ns# suh &s he l!m9h nodes

    &nd bone m&66o- F10G. %he6eo6e# i EP is &ssoi&ed -ih &nibodies 6e&hin* heCE" h6ou*h he # 6e&mens h& no onl! elimin&e b6&in=issue=6e&ive &nibodies

    bu &lso 96oe he ine*6i! o he should be onside6ed.

    %he6&9! o EP is u66enl! diiul. lhou*h o6iose6oids &nd immunosu996essive

    &*ens# suh &s !lo9hos9h&mide# &6e b6o&dl! eeive o6 EP# he ondiion iso&sion&ll! 6e6&o6! o hese 6e&mens. Mo6eove6# b6&in=issue=6e&ive

    &uo&nibodies mi*h &use i66eve6sible neu6on&l de*ene6&ion vi& &9o9osis. )o6

    ins&ne# &ni=6ibosom&l P &nibod! &6*es & neu6on&l su6&e 96oein# &usin* &lium

    inlu? &nd &9o9osis F11G. %hese &nibodies s9eii&ll! bind o neu6ons in hehi99o&m9us# in*ul&e o6e?# &nd he 96im&6! ol&o6! 9i6io6m o6e?# &nd# in mie#

    6esuled in he induion o de96ession. %hese 6esuls im9li&e he ol&o6! &nd limbi&6e&s in he 9&ho*enesis o de96ession in " F12G. %he &ni=E>2 &nibod! &lso &uses

    neu6on&l ell &9o9osis# im9&i6s he hi99o&m9us=de9enden memo6! union in mie#

    simul&es EMD 6ee9o6=medi&ed s!n&9i 6es9onses &nd e?ioo?ii! h6ou*henh&ned miohond6i&l 9e6me&bili! F13G. &nd de6e&ses ell vi&bili! h6ou*h in6e&sed

    C&2[inlu? F5G. ivi! e &l. sho-ed h& he &ni=1@/@ Id &nibod! h&m9e6s visu&l=

    6eo*niion &nd s9&i&l memo6!. %hei6 h!9ohesis &bou he 9&ho9h!siolo*! o &ni=1@/@

    Id &nibod!=indued b6&in involvemen -&s h& b6&in inl&mm&ion indues modii&iono neu6on&l union &nd neu6on&l de*ene6&ion F@G. %he &uho6s &lso ound in6e&ses in

    &s6o!e numbe6 &nd mi6o*li&l &iv&ion in he hi99o&m9us o &ni=1@/@ Id &nibod!=in(eed mie. %he! su**esed h& in6e&sed &s6o!es &nd &iv&ed mi6o*li&l ells-e6e involved in b6&in inl&mm&ion &nd he6eo6e# &n inl&mm&o6! 96oess m&! &e

    o*niive im9&i6men in mie in(eed -ih &ni=1@/@ Id &nibod!. ! on6&s# he6e -&s

    minim&l lo&l &iv&ion o &s6o!es &nd mi6o*li&l ells# &nd no l!m9ho!iinl&mm&ion in he b6&ins o &ni=E>2 &nibod!=in(eed mie F3G.

    I is 9l&usible# he6eo6e# h& he -ide v&6ie! o EP s!nd6omes mi*h be &used b!

    die6enes in he 6eo*niion o b6&in issue b! lu9us &uo&nibodies# suh &s &ni=

    6ibosom&l P# &ni=E>2# &nd &ni=1@/@ Id &nibodies. Idenii&ion &nd ev&lu&ion o suhdie6enes -ould 9e6h&9s be useul in develo9in* he6&9ies o6 EP.

    :uture directions and conclusions

    In he uu6e# i is ho9ed h& ne- &*ens -ill be develo9ed o im96ove he 96o*nosis o6EP. %he ei&! o suh ne- &*ens should be dee6mined h6ou*h hei6 &bili! o

    96oe neu6on&l ells# modul&e in6&ellul&6 C&2[# o6 6e*ul&e he de9osiion o

    &uo&nibodies in EP. Mem&nine is & d6u* used o 6e& lSheime6Ts dise&se# -hihmodul&es in6&ellul&6 C&2[b! bloin* EMD 6ee9o6s. In &ddiion# he D$+"

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B6http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B10http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B11http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B12http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B13http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B6http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B3http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B6http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B10http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B11http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B12http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B13http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B6http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B3
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    34/119

    9en&9e9ide# -hih he &ni=E>2 &nibod! 6eo*niSes &s &n &ni*en# 96evens he &ni=

    E>2 &nibod! 6om bein* de9osied in issues &nd medi&in* neu6on&l e?ioo?ii! in

    mie F14G.

    s ivi! e &l. h&ve sho-n# seve6&l &uo&nibodies &*&ins b6&in issue &6e involved in

    EP. 'iven he die6enes in he 6oss=6e&ivi! o e&h &uo&nibod! -ih hene6vous s!sem# his m&! e?9l&in he die6ene &nd dive6si! o he lini&l e&u6es in

    EP. Invesi*&o6s &nd linii&ns should onside6 no onl! inhibiion o &uo&nibod!s!nhesis bu &lso 96oeion o neu6on&l ells -hen invesi*&in* 6e&men s6&e*ies o6

    EP.

    'o o:

    A!!reviations

    C>: me6i&n olle*e o 6heum&olo*!; : loodHb6&in b&66ie6; CE": Cen6&l

    ne6vous s!sem; ds: Double=s6&nded; EMD:N=meh!l=D=&s9&6&e; EP:Eeu6o9s!hi&6i lu9us e6!hem&osus; PE": Pe6i9he6&l ne6vous s!sem; ": "!semilu9us e6!hem&osus

    'o o:

    Competin+ interests

    %he &uho6s del&6ed h& he! h&ve no om9ein* ine6es.

    'o o:

    Authors@ contri!utions

    %' d6&ed he m&nus6i9# &nd + &nd ,+ 6e&d &nd 6evised i. ll &uho6s h&ve *iven

    in&l &996ov&l o he in&l m&nus6i9 o be 9ublished.

    'o o:

    Authors@ information

    %' is &n &ssis&n 96oesso6 in he Insiue o >heum&olo*! IA>heum&olo*!# &nd &di6eo6 o he IA># %$MK. ll &uho6s &6e bo&6d=e6iied membe6s o he J&9&n

    Colle*e o >heum&olo*!.

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B14http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/#B14http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    35/119

    'o o:

    Pre*pu!lication history

    %he 96e=9ubli&ion hiso6! o6 his 9&9e6 &n be &essed he6e:

    h9://---.biomeden6&l.om/1741=7015/11/1/96e9ub

    'o o:

    )eferences

    1. %soos 'C. "!semi lu9us e6!hem&osus. E n*l J Med. 2011;11:2110H2121.

    doi: 10.105@/EJM6&110035. FPubMedG FC6oss >eG2. %he &me6i&n olle*e o 6heum&olo*! nomenl&u6e &nd &se deiniions o6

    neu6o9s!hi&6i lu9us s!nd6omes. 6h6iis >heum. 1;11:5H@08. FPubMedG3. De'io6*io # ons&ninov # ee "# ,&6din J# ol9e # Di&mond . subse o

    lu9us &ni=DE &nibodies 6oss=6e&s -ih he E>2 *lu&m&e 6ee9o6 ins!semi lu9us e6!hem&osus. E& Med. 2001;11:118H113. doi:

    10.1038/nm1101=118. FPubMedG FC6oss >eG

    4. o-&l C# De*io6*io # ee J# d*&6 M# ,ue6& P# ol9e # Di&mond . ,um&nlu9us &uo&nibodies &*&ins EMD 6ee9o6s medi&e o*niive im9&i6men.

    P6o E&l &d "i K " . 200@;11:1854H185. doi:

    10.1073/9n&s.0@0837104. FPMC 6ee &6ileG FPubMedG FC6oss >eG5. 'ono %# %&&6&d& %# )uumo6i ># &-&*uhi +# &neo ,# ,&n&o& M#

    &sum&& +# +oned& +# +&m&n&& ,. E>2=6e&ive &nibod! de6e&ses ell

    vi&bili! h6ou*h &u*men&ion o C&2[< inlu? in s!semi lu9us e6!hem&osus.6h6iis >heum. 2011;11:352H35. doi: 10.1002/&6.30@1@. FPubMedG FC6oss>eG

    @. ivi! "# &S&v # 6&n*o M%# &nd&u=>&bi M# &6i6 +# *mon=evin E#

    l&n M# n&!& JM# MoSes # Ch&9m&n J# "hoeneld +. 1@/@=Idio!9e e?96essin*&nibodies indue b6&in inl&mm&ion &nd o*niive im9&i6men in mie: he

    mos&i o en6&l ne6vous s!sem involvemen in lu9us. MC Med. 2013. FPMC

    6ee &6ileG FPubMedG7. nd6^="h-&6S J# D&& "# "hoeneld +# Isenbe6* D# "oll&6 D# "h-&6S

    >". indin* o !osele&l 96oeins b! monolon&l &ni=DE lu9us

    &uo&nibodies. Clin Immunol Immuno9&hol. 184;11:2@1H271. doi:

    10.101@/000=12284eG8. Isenbe6* D# Collins C. Deeion o 6oss=6e&ive &ni=DE &nibod! idio!9es

    on 6en&l issue=bound immuno*lobulins 6om lu9us 9&iens. J Clin Inves.

    185;11:287H24. doi: 10.1172/JCI1115. FPMC 6ee &6ileG FPubMedG FC6oss>eG

    . Isenbe6* D# "hoeneld +# M&d&io MP# >&uh J# >eihlin M# "oll&6 D#

    "h-&6S >". ni=DE &nibod! idio!9es in s!semi lu9us e6!hem&osus.&ne. 184;11:417H422. FPubMedG

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/http://www.biomedcentral.com/1741-7015/11/91/prepubhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/http://www.ncbi.nlm.nih.gov/pubmed/22129255http://dx.doi.org/10.1056%2FNEJMra1100359http://www.ncbi.nlm.nih.gov/pubmed/10211873http://www.ncbi.nlm.nih.gov/pubmed/11689882http://dx.doi.org/10.1038%2Fnm1101-1189http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1702320/http://www.ncbi.nlm.nih.gov/pubmed/17170137http://dx.doi.org/10.1073%2Fpnas.0608397104http://www.ncbi.nlm.nih.gov/pubmed/22012858http://dx.doi.org/10.1002%2Fart.30616http://dx.doi.org/10.1002%2Fart.30616http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616817/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616817/http://www.ncbi.nlm.nih.gov/pubmed/23556432http://www.ncbi.nlm.nih.gov/pubmed/6370522http://dx.doi.org/10.1016%2F0090-1229(84)90246-0http://www.ncbi.nlm.nih.gov/pmc/articles/PMC423767/http://www.ncbi.nlm.nih.gov/pubmed/3874881http://dx.doi.org/10.1172%2FJCI111959http://dx.doi.org/10.1172%2FJCI111959http://www.ncbi.nlm.nih.gov/pubmed/6147499http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/http://www.biomedcentral.com/1741-7015/11/91/prepubhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616809/http://www.ncbi.nlm.nih.gov/pubmed/22129255http://dx.doi.org/10.1056%2FNEJMra1100359http://www.ncbi.nlm.nih.gov/pubmed/10211873http://www.ncbi.nlm.nih.gov/pubmed/11689882http://dx.doi.org/10.1038%2Fnm1101-1189http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1702320/http://www.ncbi.nlm.nih.gov/pubmed/17170137http://dx.doi.org/10.1073%2Fpnas.0608397104http://www.ncbi.nlm.nih.gov/pubmed/22012858http://dx.doi.org/10.1002%2Fart.30616http://dx.doi.org/10.1002%2Fart.30616http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616817/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616817/http://www.ncbi.nlm.nih.gov/pubmed/23556432http://www.ncbi.nlm.nih.gov/pubmed/6370522http://dx.doi.org/10.1016%2F0090-1229(84)90246-0http://www.ncbi.nlm.nih.gov/pmc/articles/PMC423767/http://www.ncbi.nlm.nih.gov/pubmed/3874881http://dx.doi.org/10.1172%2FJCI111959http://dx.doi.org/10.1172%2FJCI111959http://www.ncbi.nlm.nih.gov/pubmed/6147499
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    36/119

    10. "en^&l J# >&!mond +. %he 9&ho*enesis o neu6o9s!hi&6i m&nies&ions in

    s!semi lu9us e6!hem&osus: & dise&se in se&6h o &uo&nibodies# o6

    &uo&nibodies in se&6h o & dise&seR J >heum&ol. 2004;11:203H208.FPubMedG

    11. M&us "# u6*os P# 6&vo=ehnde6 M# 6& ># Po66&s A,# )&6_&s P# &66os )#

    %o66e&lb& )# M&ss&6do # J&obelli "# 'onS`leS . ni6ibosom&l=P &uo&nibodies6om 9s!hi&6i lu9us &6*e & novel neu6on&l su6&e 96oein &usin* &lium

    inlu? &nd &9o9osis. J ?9 Med. 2007;11:3221H3234. doi:

    10.1084/(em.20071285. FPMC 6ee &6ileG FPubMedG FC6oss >eG12. &S&v # "olodeev I# 6ods! A# Ch&9m&n J# Pi C'# l&n M# h&n* $#

    >eihlin M# "hoeneld +. Induion o &uoimmune de96ession in mie b! &ni=

    6ibosom&l P &nibodies vi& he limbi s!sem. 6h6iis >heum. 2007;11:38H48.

    doi: 10.1002/&6.2241. FPubMedG FC6oss >eG13. )&us %$# Ch&n* ,# o-&l C# e6lin ># '&S&6!&n I'# e6ini # h&n* J#

    "&nheS='ue66e6o J# )6&*oso=o!o ,# ol9e %# Di&mond # ,ue6& P%.

    Eeu6oo?i lu9us &uo&nibodies &le6 b6&in union h6ou*h -o disin

    meh&nisms. P6o E&l &d "i K " . 2010;11:185@H18574. doi:10.1073/9n&s.100@80107. FPMC 6ee &6ileG FPubMedG FC6oss >eG

    14. loom A# Chen* )# ,e M# P&9&heodo6ou # ol9e %# Di&mond # l=bed +.'ene6&ion o & uniue sm&ll moleule 9e9idomimei h& neu6&liSes lu9us

    &uo&nibod! &ivi!. P6o E&l &d "i K " . 2011;11:10255H1025. doi:

    10.1073/9n&s.1103555108. FPMC 6ee &6ileG FPubMedG FC6oss >eG

    Jurnal /

    J >heum&ol. uho6 m&nus6i9; &v&il&ble in PMC 2013 96il 22.Published in in&l edied o6m &s:

    J >heum&ol. 2012 )eb6u&6!; 32CA# PhD# %>C+ I# PhD# DK" "%%># PhD# M+ ,. A#

    MD# MP,#E%+ DEC,EA# PhD# DEI DMKEDA$IC# M"# MD#

    IM "K%%AE=%+>># D6P,#>K"" P. %>C+# PhD# $I" ,. K>#MD# D6P,# &nd "K"E MEI# MD# MP,

    http://www.ncbi.nlm.nih.gov/pubmed/15517616http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150977/http://www.ncbi.nlm.nih.gov/pubmed/18056288http://dx.doi.org/10.1084%2Fjem.20071285http://www.ncbi.nlm.nih.gov/pubmed/17328071http://dx.doi.org/10.1002%2Fart.22419http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972998/http://www.ncbi.nlm.nih.gov/pubmed/20921396http://dx.doi.org/10.1073%2Fpnas.1006980107http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121823/http://www.ncbi.nlm.nih.gov/pubmed/21646518http://dx.doi.org/10.1073%2Fpnas.1103555108http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=22174200http://dx.doi.org/10.3899%2Fjrheum.110327http://www.ncbi.nlm.nih.gov/pubmed/?term=GRECO%20CM%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=LI%20T%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=SATTAR%20A%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=KAO%20AH%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=DANCHENKO%20N%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=EDMUNDOWICZ%20D%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=SUTTON-TYRRELL%20K%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=TRACY%20RP%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=TRACY%20RP%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=KULLER%20LH%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=MANZI%20S%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/15517616http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150977/http://www.ncbi.nlm.nih.gov/pubmed/18056288http://dx.doi.org/10.1084%2Fjem.20071285http://www.ncbi.nlm.nih.gov/pubmed/17328071http://dx.doi.org/10.1002%2Fart.22419http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972998/http://www.ncbi.nlm.nih.gov/pubmed/20921396http://dx.doi.org/10.1073%2Fpnas.1006980107http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121823/http://www.ncbi.nlm.nih.gov/pubmed/21646518http://dx.doi.org/10.1073%2Fpnas.1103555108http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=22174200http://dx.doi.org/10.3899%2Fjrheum.110327http://www.ncbi.nlm.nih.gov/pubmed/?term=GRECO%20CM%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=LI%20T%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=SATTAR%20A%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=KAO%20AH%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=DANCHENKO%20N%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=EDMUNDOWICZ%20D%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=SUTTON-TYRRELL%20K%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=TRACY%20RP%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=KULLER%20LH%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=MANZI%20S%5Bauth%5D
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    37/119

    uho6 ino6m&ion Co9!6i*h &nd iense ino6m&ion

    %he 9ublishe6Ns in&l edied ve6sion o his &6ile is &v&il&ble & J >heum&ol

    "ee ohe6 &6iles in PMC h& iehe 9ublished &6ile.'o o:

    A!stract

    8!9ective

    "!semi lu9us e6!hem&osus "< is & h6oni inl&mm&o6! &uoimmune dise&se -ih

    in6e&sed 96ev&lene o &6diov&sul&6 dise&se CD< &nd de96ession. lhou*h

    de96ession m&! on6ibue o CD 6is in 9o9ul&ion=b&sed sudies# is inluene on&6diov&sul&6 mo6bidi! in " h&s no been ev&lu&ed. $e ev&lu&ed he &ssoi&ion

    be-een de96ession &nd v&sul&6 dise&se in ".

    &ethods

    6oss=seion&l sud! -&s ondued 6om 2002H2005 in 1@1 -omen -ih " &nd

    -ihou CD. %he 96im&6! ouome me&su6e -&s & om9osie v&sul&6 dise&se m&6e6

    onsisin* o he 96esene o o6on&6! &6e6! &lium &nd/o6 &6oid &6e6! 9l&ue.

    )esults

    In o&l# 101 -omen me 6ie6i& o6 v&sul&6 dise&se. In un&d(used &n&l!ses# seve6&l

    6&diion&l &6diov&sul&6 6is &o6s# inl&mm&o6! m&6e6s# &di9osi!# " dise&se=6el&ed &o6s# &nd de96ession -e6e &ssoi&ed -ih v&sul&6 dise&se. In he in&l

    muliv&6i&ble model# he 9s!holo*i&l v&6i&ble de96ession -&s &ssoi&ed -ih ne&6l! 4=

    old hi*he6 odds o6 v&sul&6 dise&se A> 3.85# 5B CI 1.37# 10.87< -hen &d(used o6ohe6 6is &o6s o &*e# lo-e6 edu&ion level# h!9e6ensive s&us# -&is=hi9 6&io# &nd

    C=6e&ive 96oein.

    Conclusion

    In "# de96ession is inde9endenl! &ssoi&ed -ih v&sul&6 dise&se# &lon* -ih 9h!si&l

    &o6s.

    >ey $ndexin+ Terms7 "+"%MIC KPK" >+%,M%A"K"# C>DIA"CK>

    DI""# DP>""IAE CCI)IC%IAE# C>A%ID PQK# P"+C,A"ACI)C%A>"

    De96ession &nd &6diov&sul&6 dise&se CD< &6e &mon* he mos 96ev&len &nd

    dis&blin* ondiions -o6ld-ide# on6ibuin* o he *lob&l 9ubli he&lh bu6den1. P&iens

    di&*nosed -ih he&6 dise&se &6e & in6e&sed 6is o6 develo9in* de96ession u9 o 8 !e&6s&e6 medi&l di&*nosis2. In 9o9ul&ions inii&ll! 6ee o &6di& dise&se# de96ession

    in6e&ses 6is o6 sublini&l &he6osle6osis b! *6e&e6 h&n 2=old3#4#&nd 6is o6 iniden

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=22174200http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/citedby/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R2http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R3http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R4http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R4http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R4http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=22174200http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/citedby/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R2http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R3http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R4
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    38/119

    &6di& evens b! 50B o6 mo6e5#@# inludin* & 4.5=old in6e&sed 6is o6 m!o&6di&l

    in&6ion MI

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    39/119

    %he 9&6ii9&ns in his sud! -e6e -omen -ih " en6olled in he ,e&6 es on

    he6osle6osis &nd >is o %h6ombosis in " ,>%"< invesi*&ion# unded b! he

    E&ion&l Insiues o ,e&lh >01 >4@588%" sud! -&s oom9&6e 96ev&lene &nd 6is &o6s o6 o6on&6! &6e6! &lii&ion in -omen -ih "

    &nd he&lh! on6ols. %he 9&6ii9&ns h&d no hiso6! o CD evens 28&nd -e6e

    nonseleivel! 6e6uied 6om he Pisbu6*h u9us >e*is6!# -hih & he ime oen6ollmen inluded 83 livin* 9&6ii9&ns. %he 6e*is6! inludes 9&iens seen &

    in9&ien o6 ou9&ien &iliies & he Knive6si! o Pisbu6*h Medi&l Cene6 o6 b!

    96&iin* 6heum&olo*iss -ihin he Pisbu6*h me6o9oli&n &6e&. ll -omen -ih "-e6e 6eui6ed o ulill 182 o6 17 me6i&n Colle*e o >heum&olo*! C>< 6evised

    6ie6i& o6 he l&ssii&ion o deinie o6 96ob&ble "2#30&nd be ove6 he &*e o 18

    !e&6s.

    ll 9&6ii9&ns om9leed ino6med onsen 96oedu6es. %he sud! -&s &996oved b! heKnive6si! o Pisbu6*h Insiuion&l >evie- o&6d.

    Procedures

    %he sud! 96oedu6es inluded &n ine6vie-# om9leion o & v&lid&ed de96essionuesionn&i6e Fhe Cene6 o6 9idemiolo*i "udies De96ession "&le C"=D

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    40/119

    K"# P&6si99&n!# EJ# K".P. %6&!# Knive6si! o e6monheum&olo*iss s9ei&liSin* in " ,# "M< &ssessed dise&se &ivi! &ndumul&ive o6*&n d&m&*e due o " & he sud! visi. Me&su6es inluded he 6evised

    "!semi u9us ivi! Me&su6e "M=>

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    41/119

    9l&ue e?en# &lled he 9l&ue inde?. %he 9l&ue inde? h&s been ound o be &

    6e96oduible &nd v&lid me&su6e o &6oid &he6osle6osis in & numbe6 o 9o9ul&ions 4@.

    )o6 he u66en sud!# he 96esene o &6oid 9l&ue -&s deined &s 9l&ue inde? Z 1.

    Data analysis

    $e heed he u&li! o he d&& b! ev&lu&in* he 6euen! dis6ibuion o &ll 6elev&n

    v&6i&bles# &nd &ssessed o6 muliolline&6i! &mon* he v&6i&bles. Coninuous v&6i&bles-e6e summ&6iSed &s me&n "D< &nd &e*o6i&l v&6i&bles &s 9e6en&*es n

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    42/119

    de96essive s!m9oms. A & 9ossible 6&n*e o 0H@0# he C"=D so6e 6&n*ed 6om 0 o 45

    in he s&m9le ove6&ll. $e ev&lu&ed &ssoi&ions be-een de96ession &nd ohe6

    h&6&e6isis usin* lo*isi 6e*6ession. Alde6 &*e &nd bein* in he seond u&6ile o-&is=hi9 6&io -e6e m&6*in&ll! &ssoi&ed -ih de96ession 9 W 0.05@# 9 W 0.078#

    6es9eivel!

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    43/119

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    44/119

    9ossible biolo*i&l meh&nisms# &nd m&! &lso 6ele beh&vio6&l &nd envi6onmen&l

    inluenes on he&lh.

    De96ession is &ssoi&ed -ih in6e&ses in 96oinl&mm&o6! !oines4#50&nd hein6e&sed CD 6is in de96essed 9e6sons m&! be 6el&ed o &dded inl&mm&o6! bu6den.

    6een &se=on6ol sud! ound &n elev&ion in he 96oinl&mm&o6! !oineine6leuin @ I=@< in "# &nd his inl&mm&o6! &o6 -&s &ssoi&ed -ih CC20. %he

    &ssoi&ion be-een de96ession &nd inl&mm&ion is liel! bidi6eion&l51. ninl&mm&o6! envi6onmen# -hih is !9i&ll! 96esen in 9&iens -ih "# m&! 6esul in

    lo- mood &nd m&l&ise52.

    De96essed mood# 9&6iul&6l! -hen h6oni# m&! h&ve & ne*&ive inluene on lies!le&nd beh&vio6 hoies. )o6 e?&m9le# de96ession is & 6is &o6 o6 9oo6 medi&ion

    &dhe6ene in "25&nd in &duls -ih he&6 dise&se53. De96ession m&! ine6& -ih

    9h!si&l in&ivi! o inluene CD. Mu6ine sudies indi&e h& de96essed beh&vio6

    indued b! h6oni ine6mien s6ess led o 6edued e?e6ise &nd ulim&el! o e&6l!

    &he6osle6oi h&n*es

    54

    .In & 9o9ul&ion sud! o elde6l! men# b&seline de96essives!m9oms -e6e &ssoi&ed -ih 9h!si&l in&ivi!. %en=!e&6 6is o &6di& mo6&li! -&s

    in6e&sed &bou 50B b! he ombined ee o de96essive s!m9oms -ih in&ivi!55.

    $e onside6ed &di9osi! &s & 9oeni&l 9&h-&! linin* de96ession &nd v&sul&6 dise&se.di9osi! h&s 6eeived &enion in CD 6ese&6h be&use &di9ose issue# 9&6iul&6l!

    vise6&l &di9ose issue# is no-n o 96odue inl&mm&o6! &o6s. In & medi&ll! he&lh!

    *6ou9# de96ession -&s ound o inluene -ei*h &umul&ion# -hih led o in6e&sed96oduion o inl&mm&o6! [email protected] "# obesi! -&s 6el&ed o in6e&sed levels

    o C>P &nd I=@# &s -ell &s 6edued union&l &9&i!57. Au6 *6ou9 6eenl! ound h&

    MI medi&ed &n &ssoi&ion be-een de96essive s!m9oms &nd CC in "58.

    ,o-eve6# in ou6 u66en sud! -e ound h& even &e6 &d(usin* o6 -&is=hi9 6&io# isel&n im9o6&n 6is &o6# de96ession -&s s6on*l! &ssoi&ed o v&sul&6 dise&se.

    In "# de96ession &n be & m&nies&ion o en6&l ne6vous s!sem CE"< involvemen.

    lhou*h he l&ssii&ion 6ie6i& o6 " inlude onl! hiso6! o seiSu6es o6 9s!hosis&s he indi&o6s o neu6olo*i involvemen30#de96ession is & om9onen o

    neu6o9s!hi&6i lu9us5. Mood diso6de6s &6e inluded &mon* he 1 en6&l &nd

    9e6i9he6&l neu6o9s!hi&6i s!nd6omes lised in he 1 C> nomenl&u6e o6neu6o9s!hi&6i lu9us@0.

    $hehe6 de96ession is lined o CD in " h6ou*h beh&vio6&l 9&h-&!s# biolo*i&l

    9&h-&!s# o6 boh 6em&ins un6esolved. De96ession m&! 6esul 6om he s6u**le o o9e

    -ih & &i*uin*# 9&inul# &nd un96edi&ble h6oni ondiion. " 6euenl! is&ssoi&ed -ih -o6 dis&bili! &nd loss o inome# -hih ould on6ibue o de96ession

    &s -ell &s o 6edued &bili! o &ess he&lh&6e. De96ession &nd lo- &ess o he&lh&6e

    m&! boh on6ibue o lo- &dhe6ene -ih medi&l 6e&men# 9ossibl! 6esulin* inin6e&sed 6is o CD. An he ohe6 h&nd# de96ession m&! be & 96odu o he

    inl&mm&o6! milieu o ". %o he e?en h& inl&mm&ion on6ibues no onl! o

    CD 6is di6el! bu &lso# on &n individu&l level# o eelin*s o m&l&ise &nd lo-

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R49http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R50http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R50http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R20http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R51http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R52http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R52http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R25http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R25http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R53http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R54http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R54http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R55http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R56http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R56http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R57http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R58http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R30http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R30http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R59http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R60http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R49http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R50http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R20http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R51http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R52http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R25http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R53http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R54http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R55http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R56http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R57http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R58http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R30http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R59http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632335/#R60
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    45/119

    moiv&ion# de96ession m&! be & di6e onseuene o inl&mm&ion. ,o-eve6#

    de96ession m&! &lso &dd o inl&mm&o6! bu6den h6ou*h in6e&sed seden&6! beh&vio6#

    le&din* o in6e&sed &di9ose issue# -hih is &n &ddiion&l sou6e o inl&mm&ion. I isliel! h& 9&hs linin* de96ession -ih CD in " &6e muli&o6i&l &s -ell &s

    bidi6eion&l# &nd u6he6 invesi*&ion o hese issues is needed.

    Ane limi&ion o ou6 sud! is h& -e did no invesi*&e 96eisel! -hehe6 de96essive

    s!m9oms -e6e di6el! 6el&ed o " e.*.# & m&nies&ion o CE" lu9us< o6 indi6el!6el&ed# suh &s & 9s!hosoi&l onseuene o he lie h&n*es b6ou*h &bou b! ".

    %he 6oss=seion&l desi*n is & limi&ion h& 6es6is ou6 &bili! o ine6 h& de96ession

    o6 ohe6 6is &o6s &6e &us&ll! 6el&ed o v&sul&6 dise&se in ". P6esum&bl!# v&sul&6h&n*es &e 9l&e ove6 & lon* ime. Ce6&in 6is &o6s suh &s &di9osi! &nd

    h!9e6ension m&! be 96esumed o be lon*s&ndin*# bu u66en de96essive s!m9oms m&!

    be 6&nsien 6&he6 h&n h6oni. %he C"=D is -idel! used o6 u&ni!in* de96essives!m9oms# in " &s -ell &s ohe6 *6ou9s. ,o-eve6# -e &no-led*e h& he6e &6e ohe6

    mehods o &ssess de96ession# suh &s he "6uu6ed Clini&l Ine6vie- o6 he

    *iagnostic and #tatistical Manual of Mental *isorders

    @1

    . %he &ddiion o & di&*nosiine6vie- -ould h&ve he &dv&n&*e o doumenin* lini&l di&*nosis &s -ell &s

    h6onii! o de96ession. Ide&ll!# uu6e sudies o he biolo*i&l &nd 9s!holo*i&l 6iss

    o6 CD in " -ill inlude 96os9eive d&& olleion# mood diso6de6 di&*nosis in

    &ddiion o sel=6e9o6 s!m9oms# &nd mo6e 96eise invesi*&ion ino 9ossiblemeh&nisms linin* de96ession &nd CD.

    De96ession m&! be &ssoi&ed -ih 96em&u6e &he6osle6oi dise&se in " h6ou*h

    beh&vio6&l o6 biolo*i&l 9&h-&!s# o6 boh. In -omen -ih "# de96ession is 96ev&len

    &nd is &n im9o6&n inluene on 9h!si&l he&lh &nd omo6bidi! in &ddiion o is eeon u&li! o lie. De96ession is 6e&&ble 9h&6m&olo*i&ll! &nd h6ou*h 9s!hohe6&9!.

    enion should be 9&id o di&*nosin* &nd 6e&in* de96ession in "# &s his should noonl! on6ibue o im96oved u&li! o lie# bu 9ossibl! im96ove &dhe6ene o medi&l6e*imens &nd 9h!si&l &ivi! 6eommend&ions. %hus# im96ovin* m&n&*emen o

    de96ession m&! di6el! o6 indi6el! inluene 9h!si&l he&lh &nd ove6&ll CD 6is in

    9&iens -ih ".

    'o o:

    Ac6nowled+ments

    "u99o6ed b! he E&ion&l Insiues o ,e&lh H E&ion&l Insiue o 6h6iis#

    Musulosele&l &nd "in Dise&ses 23 >051314# >01 >4@588=01# 24 >02213=01# 23 >051044ese&6h >esou6es/'ene6&l Clini&l >ese&6hCene6 M01 >>00005@heum&olo*! >ese&6h &nd du&ion

    )ound&ion ,e&lh P6oession&l Invesi*&o6 -&6d# Ph!sii&n "ienis Develo9men

    -&6d

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    46/119

  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    47/119

    10. M&nSi "# Meil&hn # >&i6ie J# Cone C# Meds*e6 %# J&nsen=M$illi&ms # e &l. *e=

    s9eii inidene 6&es o m!o&6di&l in&6ion &nd &n*in& in -omen -ih s!semi

    lu9us e6!hem&osus: Com9&6ison -ih he )6&min*h&m "ud!. m J 9idemiol.17;145:408H15. FPubMedG

    11. $&6d M. P6em&u6e mo6bidi! 6om &6diov&sul&6 &nd e6eb6ov&sul&6 dise&ses in

    -omen -ih s!semi lu9us e6!hem&osus. 6h6iis >heum. 1;42:338H4@. FPubMedG12. >om&n M# "h&ne6 # D&vis # oshin M# "&mm&6i&no # "im&nov ># e &l.

    P6ev&lene &nd o66el&es o &ele6&ed &he6osle6osis in s!semi lu9us e6!hem&osus.

    E n*l J Med. 2003;34:23H40@. FPubMedG13. s&num& +# Aese6 # "hin&i # %u6ne6 # Alsen E# )&Sio "# e &l. P6em&u6e

    o6on&6!=&6e6! &he6osle6osis in s!semi lu9us e6!hem&osus. E n*l J Med.

    2003;34:2407H15. FPubMedG

    14. llio J># M&nSi "# "&&6 # "&nelies C# v6&m # "h&- P# e &l. C&6oid inim&=medi& hiness &nd 9l&ue 96edi uu6e &6diov&sul&6 evens in -omen -ih s!semi

    lu9us e6!hem&osus F&bs6&G 6h6iis >heum. 2008;58 "u99lheum&ol. 2004;31:713H.

    FPubMedG1@. M&nSi "# "elSe6 )# "uon=%!66ell # )iS*e6&ld "'# >&i6ie J# %6&! >P# e &l.

    P6ev&lene &nd 6is &o6s o &6oid 9l&ue in -omen -ih s!semi lu9us

    e6!hem&osus. 6h6iis >heum. 1;42:51H@0. FPubMedG17. M&simo-iS=Minnon # M&*de6 "# Pe6i M. P6edio6s o &6oid

    &he6osle6osis in s!semi lu9us e6!hem&osus. J >heum&ol. 200@;33:2458H@3.

    FPubMedG

    18. i&ni E# M&*de6 # Pe6i M. Co6on&6! &lium in s!semi lu9us e6!hem&osus is&ssoi&ed -ih 6&diion&l &6diov&sul&6 6is &o6s# bu no -ih dise&se &ivi!. J

    >heum&ol. 2008;35:1300H@. FPubMedG

    1. sd&ile J# b6&h&mo-iS M# '6odSi! %# i +# P&n&6iis C# du e6*e6 ># e &l.%6&diion&l )6&min*h&m 6is &o6s &il o ull! &oun o6 &ele6&ed &he6osle6osis in

    s!semi lu9us e6!hem&osus. 6h6iis >heum. 2001;44:2331H7. FPubMedG

    20. s&num& +# Chun* CP# Aese6 # "hin&ni # "&nle! # >&**i P# e &l. In6e&sedonen6&ion o 96o&he6o*eni inl&mm&o6! !oines in s!semi lu9us

    e6!hem&osus: 6el&ionshi9 o &6diov&sul&6 6is &o6s. J >heum&ol. 200@;33:53H45.

    FPubMedG

    21. oSo6& # llison MC# $es ". De96ession# &i*ue# &nd 9&in in s!semi lu9use6!hem&osus "heum&olo*! "

    neu6o9s!holo*i&l b&e6!. 6h6iis >heum. 200@;55:@28H35. FPubMedG

    22. "unduis # i # ,emmini # "unduis J. "ubseuen 6is o hos9i&liS&ion o6neu6o9s!hi&6i diso6de6s in 9&iens -ih 6heum&i dise&ses. 6h Ine6n Med.

    2008;@5:501H7. FPubMedG

    23. &hen # Chesne! M# C6is-ell . P6ev&lene o mood &nd &n?ie! diso6de6s in-omen -ih s!semi lu9us e6!hem&osus. 6h6iis C&6e >es. 200;@1:822H. FPMC

    6ee &6ileG FPubMedG

    http://www.ncbi.nlm.nih.gov/pubmed/9048514http://www.ncbi.nlm.nih.gov/pubmed/10025929http://www.ncbi.nlm.nih.gov/pubmed/14681505http://www.ncbi.nlm.nih.gov/pubmed/14681506http://www.ncbi.nlm.nih.gov/pubmed/15088296http://www.ncbi.nlm.nih.gov/pubmed/9920014http://www.ncbi.nlm.nih.gov/pubmed/17014002http://www.ncbi.nlm.nih.gov/pubmed/18484694http://www.ncbi.nlm.nih.gov/pubmed/11665973http://www.ncbi.nlm.nih.gov/pubmed/16463434http://www.ncbi.nlm.nih.gov/pubmed/16874786http://www.ncbi.nlm.nih.gov/pubmed/18458201http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763591/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763591/http://www.ncbi.nlm.nih.gov/pubmed/19479699http://www.ncbi.nlm.nih.gov/pubmed/9048514http://www.ncbi.nlm.nih.gov/pubmed/10025929http://www.ncbi.nlm.nih.gov/pubmed/14681505http://www.ncbi.nlm.nih.gov/pubmed/14681506http://www.ncbi.nlm.nih.gov/pubmed/15088296http://www.ncbi.nlm.nih.gov/pubmed/9920014http://www.ncbi.nlm.nih.gov/pubmed/17014002http://www.ncbi.nlm.nih.gov/pubmed/18484694http://www.ncbi.nlm.nih.gov/pubmed/11665973http://www.ncbi.nlm.nih.gov/pubmed/16463434http://www.ncbi.nlm.nih.gov/pubmed/16874786http://www.ncbi.nlm.nih.gov/pubmed/18458201http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763591/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763591/http://www.ncbi.nlm.nih.gov/pubmed/19479699
  • 8/11/2019 Aspek Psikiatrik Pada Penderita SLE

    48/119

    24. Ee6! )'# o6b& )# ,&h JP# "o&6es JC# on& # Eeo ). M&(o6 de96essive

    diso6de6 &nd dise&se &ivi! in s!semi lu9us e6!hem&osus. Com96 Ps!hi&6!.

    2007;48:14H. FPubMedG25. Juli&n J# +elin # +&Sd&n! J# P&no9&lis P# %6u9in # C6is-ell # e &l. De96ession#

    medi&ion &dhe6ene# &nd se6vie uiliS&ion in s!semi lu9us e6!hem&osus. 6h6iis

    >heum. 200;@1:240H@. FPMC 6ee &6ileG FPubMedG2@. ,&! M# ,udd! # l& D# Mb&!& P# %omenson # e6nsein >M# e &l.

    96os9eive sud! o 9s!hi&6i diso6de6 &nd o*niive union in s!semi lu9us

    e6!hem&osus. nn >heum Dis. 14;53:28H303. FPMC 6ee &6ileG FPubMedG27. %omieo P# nnese # DT*osini "# enu6ini P# & %o66e '# De i& "# e &l. 'ene6&l

    &nd s9eii &o6s &ssoi&ed -ih seve6i! o o*niive im9&i6m